
    
      We will include patients with vascular liver diseases, including

        -  portal vein thrombosis (PVT)

        -  Budd-Chiari Syndrome (BCS)

        -  Heredetary Hemorrhagic Teleangiectasia (HHT, or Osler-Rendu Disease)

        -  Noncirrhotic-portal hypertension (NCPH)

        -  Cirrhosis cardiaque if the fulfill inclusion/exclusion criteria and provide written
           informed consent. Participation in the biobank is optional for the patients. In
           particular, we will study the natural course of the patients in regard to hepatic
           decompensation (ascites, variceal bleeding, hepatic encephalopathy), need for
           intensified treatment (TIPS, ICU, liver transplantation) and survival.
    
  